What is VETMEDIN® Solution (pimobendan oral solution) ?

VETMEDIN® Solution (pimobendan oral solution) is the only oral solution product approved by the FDA. According to published studies, it helps with the management of the signs of congestive heart failure in dogs due to clinical myxomatous mitral valve disease (MMVD) or dilated cardiomyopathy (DCM).²

Suitable for:

Dogs

Benefits:

• Recommended for dogs diagnosed with congestive heart failure due to MMVD or DCM⁴
• According to published studies, helps increase the survival time and improve the quality of life in dogs with heart failure²,³
• Available as an oral solution that makes administration easy for dogs that prefer liquid medication and delivers just the right dose they need

How does VETMEDIN® Solution (pimobendan oral solution) work?

Given every 12 hours, the unique dual action of VETMEDIN dilates the blood vessels carrying blood to and from the heart—reducing the preload and afterload on the heart—while simultaneously improving contractility of the heart muscle. Pimobendan, VETMEDIN’s active ingredient, reduces stress on the heart while increasing cardiac output, without raising oxygen or energy consumption. VETMEDIN helps dogs engage in the daily activities they enjoy. Increasing age is a risk factor for heart disease and heart failure.⁴ With early diagnosis and treatment of clinical signs, you can significantly prolong your dog’s survival time and improve their quality of life. As shown in previous studies²,³ Be sure to talk to your veterinarian about VETMEDIN oral solution if your dog is in heart failure to determine the proper treatment for your pet.References: 1. VETMEDIN® Solution (pimobendan oral solution) [Freedom of Information Summary; NADA 141-273]. St. Joseph, MO: Boehringer Ingelheim Vetmedica, Inc.; 2007. 2. Häggström J, Boswood A, O’Grady M, et al. Effect of pimobendan or benazepril hydrochloride on survival times in dogs with congestive heart failure caused by naturally occurring myxomatous mitral valve disease: the QUEST study. J Vet Intern Med. 2008;22(5):1124-1135. 3. Lombard CW, Jöns O, Bussadori CM; for the VetSCOPE Study. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs. J Am Anim Hosp Assoc. 2006;42(4):249-261. 4. Keene et al ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs J Vet Intern Med 2019.

How should I store this product?

Store at or below 77°F (25°C) with excursions permitted up to 86°F (30°C). Once the bottle is opened, use the contents within 8 weeks.

How should VETMEDIN® Solution (pimobendan oral solution) be given/administered?

VETMEDIN® Solution (pimobendan oral solution) should be administered directly in the mouth (orally) at a total daily dose of 0.23 mg/lb (0.5 mg/kg) body weight. Do not mix into food. The total daily dose should be divided into 2 equal portions administered approximately 12 hours apart (ie., morning and evening). The syringe is calibrated to deliver the appropriate morning or evening dose when drawn to the dog's nearest weight in pounds, each dose should be rounded up to the nearest 1 lb. increment. Do NOT shake the bottle before or after to avoid foaming.

What are the potential side effects of VETMEDIN® Solution (pimobendan oral solution) ?

The most common side effects are poor appetite, lethargy, diarrhea, shortness of breath, weakness, and ataxia (lack of muscle control and coordination). If side effects occur, consult your veterinarian. The safety of VETMEDIN® Solution (pimobendan oral solution) inodilator has not been established in puppies younger than 6 months of age, or in breeding, pregnant or lactating dogs. For more information, please see full prescribing information.